CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900943402
- Phone
- 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-02 | Ganot Ilan Director | Option exercise | +1,584 | 86,175 | ||
| 2023-03-02 | Ganot Ilan Director | Option exercise · Restricted Stock Units | −1,584 | 4,749 | ||
| 2023-01-27 | Morris Carl Ashley Chief Scientific Officer | Option exercise | +1,233 | 20,201 | ||
| 2023-01-27 | Morris Carl Ashley Chief Scientific Officer | Sale | −441 | $7.49 | $3K | 19,760 |
| 2023-01-27 | Morris Carl Ashley Chief Scientific Officer | Option exercise · Restricted Stock Units | −1,233 | 3,700 | ||
| 2023-01-27 | Ganot Ilan Director | Option exercise | +388 | 1,519 | ||
| 2023-01-27 | Ganot Ilan Director | Sale | −141 | $7.49 | $1K | 1,378 |
| 2023-01-27 | Ganot Ilan Director | Option exercise | +3,883 | 85,973 | ||
| 2023-01-27 | Ganot Ilan Director | Sale | −1,382 | $7.49 | $10K | 84,591 |
| 2023-01-27 | Ganot Ilan Director | Option exercise · Restricted Stock Units | −388 | 1,165 | ||
| 2023-01-27 | Ganot Ilan Director | Option exercise · Restricted Stock Units | −3,883 | 11,650 | ||
| 2023-01-09 | Tan Kevin CFO & Treasurer | Grant or award · Employee Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2023-01-09 | Tan Kevin CFO & Treasurer | Grant or award · Restricted Stock Units | +45,000 | 45,000 | ||
| 2023-01-03 | Morris Carl Ashley Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +95,110 | 95,110 | ||
| 2023-01-03 | Morris Carl Ashley Chief Scientific Officer | Grant or award · Restricted Stock Units | +47,555 | 47,555 | ||
| 2023-01-03 | SMITH IAN F Director | Option exercise | +1,620 | 37,670 | ||
| 2023-01-03 | SMITH IAN F Director | Option exercise · Restricted Stock Units | −1,620 | 0 | ||
| 2023-01-03 | SMITH IAN F Director | Option exercise · Stock Option (Right to Buy) | +70,796 | 70,796 | ||
| 2023-01-03 | SMITH IAN F Director | Grant or award · Restricted Stock Units | +62,278 | 62,278 | ||
| 2023-01-03 | Ganot Ilan Director | Grant or award · Employee Stock Option (Right to Buy) | +23,950 | 23,950 |
Page 17 of 21 · 403 trades